Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation

Detalhes bibliográficos
Autor(a) principal: Lopes, Marlene A.
Data de Publicação: 2015
Outros Autores: Abrahim-Vieira, Bárbara, Oliveira, Claudia, Fonte, Pedro, Souza, Alessandra M. T., Lira, Tammy, Sequeira, Joana A. D., Rodrigues, Carlos R., Cabral, Lúcio M., Sarmento, Bruno, Seiça, Raquel, Veiga, Francisco, Ribeiro, António J.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/109172
https://doi.org/10.2147/IJN.S86313
Resumo: Alginate-dextran sulfate-based particles obtained by emulsification/internal gelation technology can be considered suitable carriers for oral insulin delivery. A rational study focused on the emulsification and particle recovery steps was developed in order to reduce particles to the nanosize range while keeping insulin bioactivity. There was a decrease in size when ultrasonication was used during emulsification, which was more pronounced when a cosurfactant was added. Ultrasonication add-on after particle recovery decreased aggregation and led to a narrower nanoscale particle-size distribution. Insulin encapsulation efficiency was 99.3%±0.5%, attributed to the strong pH-stabilizing electrostatic effect between insulin and nanoparticle matrix polymers. Interactions between these polymers and insulin were predicted using molecular modeling studies through quantum mechanics calculations that allowed for prediction of the interaction model. In vitro release studies indicated well-preserved integrity of nanoparticles in simulated gastric fluid. Circular dichroism spectroscopy proved conformational stability of insulin and Fourier transform infrared spectroscopy technique showed rearrangements of insulin structure during processing. Moreover, in vivo biological activity in diabetic rats revealed no statistical difference when compared to nonencapsulated insulin, demonstrating retention of insulin activity. Our results demonstrate that alginate-dextran sulfate-based nanoparticles efficiently stabilize the loaded protein structure, presenting good physical properties for oral delivery of insulin.
id RCAP_e5c600885daa284a5d9e0bf83e4d2732
oai_identifier_str oai:estudogeral.uc.pt:10316/109172
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelationbiopolymersinsulin secondary structuremicroparticlemolecular modelingnanoencapsulation processingoral deliveryAlginatesAnimalsDextran SulfateDiabetes Mellitus, ExperimentalGelsGlucuronic AcidHexuronic AcidsHydrogen-Ion ConcentrationHypoglycemic AgentsInsulinMaleNanoparticlesRatsRats, WistarUltrasonicsEmulsionsAlginate-dextran sulfate-based particles obtained by emulsification/internal gelation technology can be considered suitable carriers for oral insulin delivery. A rational study focused on the emulsification and particle recovery steps was developed in order to reduce particles to the nanosize range while keeping insulin bioactivity. There was a decrease in size when ultrasonication was used during emulsification, which was more pronounced when a cosurfactant was added. Ultrasonication add-on after particle recovery decreased aggregation and led to a narrower nanoscale particle-size distribution. Insulin encapsulation efficiency was 99.3%±0.5%, attributed to the strong pH-stabilizing electrostatic effect between insulin and nanoparticle matrix polymers. Interactions between these polymers and insulin were predicted using molecular modeling studies through quantum mechanics calculations that allowed for prediction of the interaction model. In vitro release studies indicated well-preserved integrity of nanoparticles in simulated gastric fluid. Circular dichroism spectroscopy proved conformational stability of insulin and Fourier transform infrared spectroscopy technique showed rearrangements of insulin structure during processing. Moreover, in vivo biological activity in diabetic rats revealed no statistical difference when compared to nonencapsulated insulin, demonstrating retention of insulin activity. Our results demonstrate that alginate-dextran sulfate-based nanoparticles efficiently stabilize the loaded protein structure, presenting good physical properties for oral delivery of insulin.Dove Medical Press2015info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/109172http://hdl.handle.net/10316/109172https://doi.org/10.2147/IJN.S86313eng1178-2013Lopes, Marlene A.Abrahim-Vieira, BárbaraOliveira, ClaudiaFonte, PedroSouza, Alessandra M. T.Lira, TammySequeira, Joana A. D.Rodrigues, Carlos R.Cabral, Lúcio M.Sarmento, BrunoSeiça, RaquelVeiga, FranciscoRibeiro, António J.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-09-29T14:55:52Zoai:estudogeral.uc.pt:10316/109172Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:25:22.118549Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
spellingShingle Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
Lopes, Marlene A.
biopolymers
insulin secondary structure
microparticle
molecular modeling
nanoencapsulation processing
oral delivery
Alginates
Animals
Dextran Sulfate
Diabetes Mellitus, Experimental
Gels
Glucuronic Acid
Hexuronic Acids
Hydrogen-Ion Concentration
Hypoglycemic Agents
Insulin
Male
Nanoparticles
Rats
Rats, Wistar
Ultrasonics
Emulsions
title_short Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_full Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_fullStr Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_full_unstemmed Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_sort Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
author Lopes, Marlene A.
author_facet Lopes, Marlene A.
Abrahim-Vieira, Bárbara
Oliveira, Claudia
Fonte, Pedro
Souza, Alessandra M. T.
Lira, Tammy
Sequeira, Joana A. D.
Rodrigues, Carlos R.
Cabral, Lúcio M.
Sarmento, Bruno
Seiça, Raquel
Veiga, Francisco
Ribeiro, António J.
author_role author
author2 Abrahim-Vieira, Bárbara
Oliveira, Claudia
Fonte, Pedro
Souza, Alessandra M. T.
Lira, Tammy
Sequeira, Joana A. D.
Rodrigues, Carlos R.
Cabral, Lúcio M.
Sarmento, Bruno
Seiça, Raquel
Veiga, Francisco
Ribeiro, António J.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lopes, Marlene A.
Abrahim-Vieira, Bárbara
Oliveira, Claudia
Fonte, Pedro
Souza, Alessandra M. T.
Lira, Tammy
Sequeira, Joana A. D.
Rodrigues, Carlos R.
Cabral, Lúcio M.
Sarmento, Bruno
Seiça, Raquel
Veiga, Francisco
Ribeiro, António J.
dc.subject.por.fl_str_mv biopolymers
insulin secondary structure
microparticle
molecular modeling
nanoencapsulation processing
oral delivery
Alginates
Animals
Dextran Sulfate
Diabetes Mellitus, Experimental
Gels
Glucuronic Acid
Hexuronic Acids
Hydrogen-Ion Concentration
Hypoglycemic Agents
Insulin
Male
Nanoparticles
Rats
Rats, Wistar
Ultrasonics
Emulsions
topic biopolymers
insulin secondary structure
microparticle
molecular modeling
nanoencapsulation processing
oral delivery
Alginates
Animals
Dextran Sulfate
Diabetes Mellitus, Experimental
Gels
Glucuronic Acid
Hexuronic Acids
Hydrogen-Ion Concentration
Hypoglycemic Agents
Insulin
Male
Nanoparticles
Rats
Rats, Wistar
Ultrasonics
Emulsions
description Alginate-dextran sulfate-based particles obtained by emulsification/internal gelation technology can be considered suitable carriers for oral insulin delivery. A rational study focused on the emulsification and particle recovery steps was developed in order to reduce particles to the nanosize range while keeping insulin bioactivity. There was a decrease in size when ultrasonication was used during emulsification, which was more pronounced when a cosurfactant was added. Ultrasonication add-on after particle recovery decreased aggregation and led to a narrower nanoscale particle-size distribution. Insulin encapsulation efficiency was 99.3%±0.5%, attributed to the strong pH-stabilizing electrostatic effect between insulin and nanoparticle matrix polymers. Interactions between these polymers and insulin were predicted using molecular modeling studies through quantum mechanics calculations that allowed for prediction of the interaction model. In vitro release studies indicated well-preserved integrity of nanoparticles in simulated gastric fluid. Circular dichroism spectroscopy proved conformational stability of insulin and Fourier transform infrared spectroscopy technique showed rearrangements of insulin structure during processing. Moreover, in vivo biological activity in diabetic rats revealed no statistical difference when compared to nonencapsulated insulin, demonstrating retention of insulin activity. Our results demonstrate that alginate-dextran sulfate-based nanoparticles efficiently stabilize the loaded protein structure, presenting good physical properties for oral delivery of insulin.
publishDate 2015
dc.date.none.fl_str_mv 2015
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/109172
http://hdl.handle.net/10316/109172
https://doi.org/10.2147/IJN.S86313
url http://hdl.handle.net/10316/109172
https://doi.org/10.2147/IJN.S86313
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1178-2013
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Dove Medical Press
publisher.none.fl_str_mv Dove Medical Press
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134136476106752